Correlation Between Pfizer and Innovator

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Innovator at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Innovator into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Innovator SP 500, you can compare the effects of market volatilities on Pfizer and Innovator and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Innovator. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Innovator.

Diversification Opportunities for Pfizer and Innovator

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and Innovator is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Innovator SP 500 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator SP 500 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Innovator. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator SP 500 has no effect on the direction of Pfizer i.e., Pfizer and Innovator go up and down completely randomly.

Pair Corralation between Pfizer and Innovator

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Innovator. In addition to that, Pfizer is 8.2 times more volatile than Innovator SP 500. It trades about -0.08 of its total potential returns per unit of risk. Innovator SP 500 is currently generating about 0.29 per unit of volatility. If you would invest  3,752  in Innovator SP 500 on September 3, 2024 and sell it today you would earn a total of  123.00  from holding Innovator SP 500 or generate 3.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Innovator SP 500

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Innovator SP 500 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Innovator SP 500 are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Innovator is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pfizer and Innovator Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Innovator

The main advantage of trading using opposite Pfizer and Innovator positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Innovator can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator will offset losses from the drop in Innovator's long position.
The idea behind Pfizer Inc and Innovator SP 500 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity